XOMA Adds Economic Interests in Three First-in-Category Assets to its[...]
Cero Therapeutics Holdings Inc.
TIM-4-L-targeting CER-1236 Engineered T cells Eliminate Adverse-Risk[...]
04/17/2024 | Press release | Distributed by Public on 04/17/2024 07:12
Please select the service you want to use:
Smartlinks | FHLBanks Office of Finance | Council of Federal Home Loan Banks | News | Local News | Private Companies | Banks
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact